Your session is about to expire
← Back to Search
Small-Volume Tubes for Anemia (STRATUS Trial)
N/A
Waitlist Available
Led By Deborah Siegal, MD MSc FRCPC
Research Sponsored by Population Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1.5 years
Awards & highlights
STRATUS Trial Summary
This trial will test whether using smaller blood-collection tubes for lab testing will reduce anemia and transfusions in ICU patients, with no significant adverse consequences.
Who is the study for?
This trial is for adult patients in the ICU with access to mechanical ventilation. Hospitals must use vacuum tubes for blood collection and be able to reduce blood volume drawn by at least 25% using small-volume tubes. They need electronic health records for data collection.Check my eligibility
What is being tested?
The STRATUS trial is testing if using small-volume ('soft-draw') blood collection tubes instead of standard ones can reduce anemia and the need for transfusions in ICU patients, without causing harm.See study design
What are the potential side effects?
There are no direct side effects mentioned from using small-volume blood collection tubes, but potential risks may include insufficient sample volumes leading to repeated draws or inaccurate lab results.
STRATUS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1.5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1.5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
RBC Transfusions
Secondary outcome measures
Hemoglobin Concentration
ICU and hospital length of stay
ICU and hospital mortality
STRATUS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention PeriodExperimental Treatment1 Intervention
Small-Volume Blood Collection Tubes ("soft-draw")
Group II: Control PeriodActive Control1 Intervention
Standard-Volume Blood Collection Tubes
Find a Location
Who is running the clinical trial?
Population Health Research InstituteLead Sponsor
155 Previous Clinical Trials
669,912 Total Patients Enrolled
1 Trials studying Anemia
369 Patients Enrolled for Anemia
Stuart Connolly, MDStudy ChairPopulation Health Research Institute; McMaster University
8 Previous Clinical Trials
12,115 Total Patients Enrolled
1 Trials studying Anemia
369 Patients Enrolled for Anemia
Deborah Siegal, MD MSc FRCPCPrincipal InvestigatorPopulation Health Research Institute; McMaster University
1 Previous Clinical Trials
242 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Control Period
- Group 2: Intervention Period
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any current openings for individuals to participate in this research?
"This clinical trial is no longer actively recruiting patients, as per information hosted on the website of clinicaltrials.gov. The original posting was made public in January 2019, and the last update occurred in May 2022. Nonetheless, there are 223 other trials that currently require enrolment from volunteers at this juncture."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger